Congress trades

Perrigo Company plc (PRGO)

NYSE · Healthcare · 71 congress trades · last filed 3 years ago

20
Congress disclosures shown
36d
Median delay on the congress disclosures
of the 45 day limit
1 buy·19 sells
Purchases and sales in the disclosures shown
Get a push when a member of Congress trades PRGO.

Free on iOS and Android.

About Perrigo Company plc

from the company's filings and listing, as of Oct 25, 2026
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chief executive
Albert A. Manzone
Employees
8,100
Listed since
Dec 17, 1991
Market value
$2.2B
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-$12.47
Dividend yield
7.27%

www.perrigo.com

Earnings

6 reported quarters · next on Nov 4, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Aug 5, 2026$0.50$0.39$1.0B$1.0BEPS beatRevenue in line
Q1 FY2026reported May 6, 2026$0.43$0.39$969.2M$1.0BEPS beatRevenue miss
Q4 FY2025reported Feb 26, 2026$0.77$0.80$1.1B$1.1BEPS missRevenue in line
Q3 FY2025reported Nov 5, 2025$0.80$0.75$1.0B$1.1BEPS beatRevenue miss
Q2 FY2025reported Aug 6, 2025$0.57$0.59$1.1B$1.1BEPS missRevenue miss
Q1 FY2025reported May 7, 2025$0.60$0.56$1.0B$1.1BEPS beatRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for fiscal 2025 · proxy filed Mar 20, 2026
ExecutiveSalaryStock awardsOtherTotal
Patrick Lockwood-TaylorCEO, President$1.2M$7.0M$829K$9.0M
Eduardo BezerraEVP, CFO$778K$2.5M$350K$3.7M
Roberto KhouryEVP, Chief Commercial Officer$659K$2.2M$329K$3.1M
Abbie LennoxEVP, Chief Scientific Officer$648K$1.3M$1.0M$3.0M
Charles AtkinsonEVP, General Counsel and Secretary$760K$1.9M$288K$2.9M

The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. 2 executives who have since left the company are named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesShares vs prior qtr% of shares out
BlackRock, Inc.$235.9M22,703,127+32.6%16.32%
Neuberger Berman Group LLC$111.0M10,680,100+2.1%7.68%
Vanguard Portfolio Management LLC$94.0M9,045,661+11.1%6.50%
T. Rowe Price Associates, Inc.$90.4M8,700,421-35.0%6.25%
State Street Corp$88.7M8,528,704+18.0%6.15%
Fuller & Thaler Asset Management, Inc.$77.9M7,498,227-2.1%5.39%
Vanguard Capital Management LLC$64.9M6,245,418+0.6%4.49%
Invesco Ltd.$61.0M5,866,702+24.5%4.22%
Dimensional Fund Advisors LP$56.8M5,467,098-16.8%3.93%
Menora Mivtachim Holdings Ltd.$45.7M4,394,318+13.5%3.16%
Geode Capital Management, LLC$37.6M3,622,308+58.1%2.60%
AQR Capital Management LLCCliff Asness$35.3M3,480,666+409.8%2.50%

A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.

Know when the next PRGO filing is reported.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in PRGO

20 disclosures of 71 on record · median 36d of the 45 allowed

Since the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.

MemberTypeActionAmount disclosedStock since the tradeTrade dateDisclosedDelay
Michael T. McCaulStockSale$15,001 - $50,000-50.2%After the saleS&P 500 +80.3% · -130.5 pts vs S&P 500Jun 1, 2023Jul 19, 202348d
Michael T. McCaulStockSale$1,001 - $15,000-50.2%After the saleS&P 500 +80.3% · -130.5 pts vs S&P 500Jun 1, 2023Jul 19, 202348d
Michael T. McCaulStockSale$1,001 - $15,000-51.6%After the saleS&P 500 +77.6% · -129.3 pts vs S&P 500Jun 2, 2023Jul 19, 202347d
Michael T. McCaulStockSale$15,001 - $50,000-51.6%After the saleS&P 500 +77.6% · -129.3 pts vs S&P 500Jun 2, 2023Jul 19, 202347d
Michael T. McCaulStockSale$1,001 - $15,000-51.7%After the saleS&P 500 +78.0% · -129.7 pts vs S&P 500Jun 5, 2023Jul 19, 202344d
Michael T. McCaulStockSale$15,001 - $50,000-51.7%After the saleS&P 500 +78.0% · -129.7 pts vs S&P 500Jun 5, 2023Jul 19, 202344d
Michael T. McCaulStockSale$1,001 - $15,000-53.3%After the saleS&P 500 +73.5% · -126.8 pts vs S&P 500Jun 22, 2023Jul 19, 202327d
Michael T. McCaulStockSale$15,001 - $50,000-53.3%After the saleS&P 500 +73.5% · -126.8 pts vs S&P 500Jun 22, 2023Jul 19, 202327d
Michael T. McCaulStockSale$1,001 - $15,000-52.4%After the saleS&P 500 +74.8% · -127.2 pts vs S&P 500Jun 23, 2023Jul 19, 202326d
Michael T. McCaulStockSale$1,001 - $15,000-52.3%After the saleS&P 500 +75.5% · -127.8 pts vs S&P 500Jun 26, 2023Jul 19, 202323d
Michael T. McCaulStockSale$15,001 - $50,000-52.0%After the saleS&P 500 +73.5% · -125.5 pts vs S&P 500Jun 28, 2023Jul 19, 202321d
Michael T. McCaulStockSale$1,001 - $15,000-52.0%After the saleS&P 500 +73.5% · -125.5 pts vs S&P 500Jun 28, 2023Jul 19, 202321d
Michael T. McCaulStockSale$15,001 - $50,000-52.6%After the saleS&P 500 +73.6% · -126.1 pts vs S&P 500Jun 29, 2023Jul 19, 202320d
Michael T. McCaulStockSale$100,001 - $250,000-54.7%After the saleS&P 500 +84.7% · -139.4 pts vs S&P 500May 12, 2023Jun 22, 202341d
Michael T. McCaulStockSale$15,001 - $50,000-54.7%After the saleS&P 500 +84.7% · -139.4 pts vs S&P 500May 12, 2023Jun 22, 202341d
Michael T. McCaulStockSale$15,001 - $50,000-51.4%After the saleS&P 500 +83.1% · -134.6 pts vs S&P 500May 17, 2023Jun 22, 202336d
Michael T. McCaulStockSale$50,001 - $100,000-51.4%After the saleS&P 500 +83.1% · -134.6 pts vs S&P 500May 17, 2023Jun 22, 202336d
Michael T. McCaulStockSale$15,001 - $50,000-52.3%After the saleS&P 500 +81.4% · -133.6 pts vs S&P 500May 18, 2023Jun 22, 202335d
Michael T. McCaulStockSale$50,001 - $100,000-52.3%After the saleS&P 500 +81.4% · -133.6 pts vs S&P 500May 18, 2023Jun 22, 202335d
Michael T. McCaulStockPurchase$15,001 - $50,000-58.6%S&P 500 +92.9% · -151.4 pts vs S&P 500May 24, 2022Jun 14, 202221d

Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in PRGO, filterable by party, chamber, type and account.

Questions

Which members of Congress have traded PRGO?

Michael T. McCaul disclosed PRGO transactions in the filings shown here.

How quickly are PRGO trades disclosed?

Congressional disclosures took a median of 36 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days after the trade, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Oct 26, 2026.

Related companies

traded by the same members

See every company we track